Geller Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $970K | Sell |
14,809
-1,840
| -11% | -$121K | 0.06% | 68 |
|
|
2024
Q3 | $1.3M | Buy |
16,649
+46
| +0.3% | +$3.58K | 0.09% | 58 |
|
|
2024
Q2 | $1.29M | Buy |
16,603
+798
| +5% | +$62.2K | 0.1% | 60 |
|
|
2024
Q1 | $1.07M | Buy |
15,805
+60
| +0.4% | +$4.07K | 0.09% | 70 |
|
|
2023
Q4 | $1.06M | Sell |
15,745
-80
| -0.5% | -$5.39K | 0.1% | 66 |
|
|
2023
Q3 | $1.07M | Sell |
15,825
-65
| -0.4% | -$4.4K | 0.12% | 51 |
|
|
2023
Q2 | $1.14M | Buy |
15,890
+6,555
| +70% | +$469K | 0.14% | 47 |
|
|
2023
Q1 | $648K | Buy |
9,335
+4,462
| +92% | +$310K | 0.1% | 49 |
|
|
2022
Q4 | $330K | Sell |
4,873
-288
| -6% | -$19.5K | 0.06% | 86 |
|
|
2022
Q3 | $283K | Sell |
5,161
-494
| -9% | -$27.1K | 0.06% | 85 |
|
|
2022
Q2 | $374K | Sell |
5,655
-2,148
| -28% | -$142K | 0.08% | 67 |
|
|
2022
Q1 | $518K | Sell |
7,803
-85
| -1% | -$5.64K | 0.1% | 55 |
|
|
2021
Q4 | $459K | Hold |
7,888
| – | – | 0.09% | 69 |
|
|
2021
Q3 | $474K | Buy |
7,888
+1,118
| +17% | +$67.2K | 0.1% | 58 |
|
|
2021
Q2 | $406K | Buy |
+6,770
| New | +$406K | 0.09% | 64 |
|
|
2021
Q1 | – | Sell |
-5,321
| Closed | -$264K | – | 122 |
|
|
2020
Q4 | $264K | Hold |
5,321
| – | – | 0.07% | 86 |
|
|
2020
Q3 | $292K | Buy |
5,321
+2
| +0% | +$110 | 0.08% | 58 |
|
|
2020
Q2 | $281K | Buy |
+5,319
| New | +$281K | 0.09% | 60 |
|